Cargando…
Translational and clinical advances in acute graft-versus-host disease
Acute graft-versus-host disease (aGvHD) is induced by immunocompetent alloreactive T lymphocytes in the donor graft responding to polymorphic and non-polymorphic host antigens and causing inflammation in primarily the skin, gastrointestinal tract and liver. aGvHD remains an important toxicity of all...
Autores principales: | Gooptu, Mahasweta, Koreth, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604566/ https://www.ncbi.nlm.nih.gov/pubmed/33054103 http://dx.doi.org/10.3324/haematol.2019.240309 |
Ejemplares similares
-
Advances in the treatment of acute graft-versus-host disease
por: Qian, Liren, et al.
Publicado: (2013) -
Resolution of Inflammation in Acute Graft-Versus-Host-Disease: Advances and Perspectives
por: Duarte, Layara Roberta Ferreira, et al.
Publicado: (2022) -
Acute graft versus host disease
por: Jacobsohn, David A, et al.
Publicado: (2007) -
Recent advances in graft-versus-host disease
por: Flinn, Aisling M, et al.
Publicado: (2023) -
Durability of clinical and immunologic responses to extended low-dose interleukin-2 therapy in patients with refractory chronic graft-versus-host disease
por: Donato, Veronica, et al.
Publicado: (2022)